STRATA Skin Sciences Inc. (SSKN)
STRATA Skin Sciences Statistics
Share Statistics
STRATA Skin Sciences has 4.17M shares outstanding. The number of shares has increased by 18.97% in one year.
| Shares Outstanding | 4.17M |
| Shares Change (YoY) | 18.97% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.03% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 15 |
| FTD / Avg. Volume | 0.59% |
Short Selling Information
The latest short interest is 1.15K, so 0.03% of the outstanding shares have been sold short.
| Short Interest | 1.15K |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -1.1 and the forward PE ratio is -5.16. STRATA Skin Sciences's PEG ratio is 0.08.
| PE Ratio | -1.1 |
| Forward PE | -5.16 |
| PS Ratio | 0.33 |
| Forward PS | 0.3 |
| PB Ratio | 2.23 |
| P/FCF Ratio | -7.65 |
| PEG Ratio | 0.08 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for STRATA Skin Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.13 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | -0.44 |
| Debt / FCF | -0.86 |
| Interest Coverage | -4.39 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $316,622.64 |
| Profits Per Employee | $-95,150.94 |
| Employee Count | 106 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 6.45 |
Taxes
| Income Tax | -170K |
| Effective Tax Rate | 1.66% |
Stock Price Statistics
The stock price has increased by -32.5% in the last 52 weeks. The beta is 1.09, so STRATA Skin Sciences's price volatility has been higher than the market average.
| Beta | 1.09 |
| 52-Week Price Change | -32.5% |
| 50-Day Moving Average | 2.65 |
| 200-Day Moving Average | 2.92 |
| Relative Strength Index (RSI) | 55.72 |
| Average Volume (20 Days) | 2,536 |
Income Statement
In the last 12 months, STRATA Skin Sciences had revenue of 33.56M and earned -10.09M in profits. Earnings per share was -2.65.
| Revenue | 33.56M |
| Gross Profit | 19.08M |
| Operating Income | -9.26M |
| Net Income | -10.09M |
| EBITDA | -2.84M |
| EBIT | -8.15M |
| Earnings Per Share (EPS) | -2.65 |
Balance Sheet
The company has 7.26M in cash and 1.25M in debt, giving a net cash position of 6.01M.
| Cash & Cash Equivalents | 7.26M |
| Total Debt | 1.25M |
| Net Cash | 6.01M |
| Retained Earnings | -248.14M |
| Total Assets | 36.16M |
| Working Capital | 1.97M |
Cash Flow
In the last 12 months, operating cash flow was 188K and capital expenditures -1.64M, giving a free cash flow of -1.45M.
| Operating Cash Flow | 188K |
| Capital Expenditures | -1.64M |
| Free Cash Flow | -1.45M |
| FCF Per Share | -0.38 |
Margins
Gross margin is 56.85%, with operating and profit margins of -27.58% and -30.05%.
| Gross Margin | 56.85% |
| Operating Margin | -27.58% |
| Pretax Margin | -30.56% |
| Profit Margin | -30.05% |
| EBITDA Margin | -8.47% |
| EBIT Margin | -27.58% |
| FCF Margin | -4.31% |
Dividends & Yields
SSKN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SSKN is $6, which is 122.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $6 |
| Price Target Difference | 122.2% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jun 7, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Jun 7, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -9.05 |
| Piotroski F-Score | 3 |